Drug Database
Back to search

Belgium· BE-AMP-SAM505244-00

Zepatier 50 mg - 100 mg

A elbasvir and grazoprevir product containing elbasvir, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 11 of our 19 countries.

ATC J05AP54

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedZepatier 50 mg - 100 mgATCJ05AP54REGISTER NO.BE-AMP-SAM505244-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about elbasvirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Elbasvir and grazoprevir is registered in 11 of 19 countries.

Countries holding a registration under ATC J05AP54 (elbasvir and grazoprevir), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search elbasvir and grazoprevir products by name

Elbasvir and grazoprevir · ATC J05AP54

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Elbasvir
Manufacturer
Merck Sharp & Dohme
Country
Belgium (BE)
ATC code
J05AP54
ATC class
Elbasvir and grazoprevir
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    7717713
  • be_apb
    3456563
  • be_apb
    3649142

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J05AP54

Elbasvir and grazoprevir, as other registers publish it.

All elbasvir and grazoprevir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a0f0e2c2-aa6d-429c-be40-7e6a0ddb184f
GET /v1/drugs/a0f0e2c2-aa6d-429c-be40-7e6a0ddb184f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Zepatier 50 mg - 100 mg",
  "name_fr": "Zepatier 50 mg - 100 mg",
  "name_nl": "Zepatier 50 mg - 100 mg",
  "amp_code": "SAM505244-00",
  "strengths": [
    "50.0000",
    "100.0000",
    "87.0200",
    "3.0400"
  ],
  "pack_count": 2,
  "substances": [
    "Elbasvir",
    "Grazoprevir",
    "Lactose",
    "Mannitol",
    "Sodium Chloride",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Elbasvir and Grazoprevir",
  "authorisation_numbers": [
    "EU/1/16/1119/001"
  ]
}
API referenceMCP serverPlans

See everything about elbasvir and grazoprevir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console